2016
DOI: 10.1080/17425247.2016.1213241
|View full text |Cite
|
Sign up to set email alerts
|

Triggered-release drug delivery nanosystems for cancer therapy by intravenous injection: where are we now?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(10 citation statements)
references
References 17 publications
0
10
0
Order By: Relevance
“…It was deduced that the cavitation effect of US changed the interior volume and flexibility of surface PDMS, opened the nanovalves and triggered the drug releasing subsequently. However, the traditional sealing of drug molecules within the mesopores by designing various caps on the mesopore surface is relatively not practical for clinical translation because the capping process was a bit complicated and might cause the potential toxicity . We recently incorporated organic groups (e.g., R = phenylene or thioether) within the framework of mesoporous silica to fabricate molecularly organic/inorganic‐hybrid mesoporous organosilica NPs (MONs, Figure d and e) .…”
Section: Us‐triggered Responsive Drug Releasing and Gene Transfectionmentioning
confidence: 99%
“…It was deduced that the cavitation effect of US changed the interior volume and flexibility of surface PDMS, opened the nanovalves and triggered the drug releasing subsequently. However, the traditional sealing of drug molecules within the mesopores by designing various caps on the mesopore surface is relatively not practical for clinical translation because the capping process was a bit complicated and might cause the potential toxicity . We recently incorporated organic groups (e.g., R = phenylene or thioether) within the framework of mesoporous silica to fabricate molecularly organic/inorganic‐hybrid mesoporous organosilica NPs (MONs, Figure d and e) .…”
Section: Us‐triggered Responsive Drug Releasing and Gene Transfectionmentioning
confidence: 99%
“…From this section, we explain both concepts into the boundary of “active delivery,” as the technique selectively marks the target tumor cells depending on nanoparticle-cell interaction under specific target cell conditions. 105 The representative publications for absorption spectrum shift are summarized in Table V .…”
Section: Functionalizing P Cs and N Cs As A Photoacoustic Contrast Agentmentioning
confidence: 99%
“…The drug delivery and therapeutic potential of AuNPs can be greatly enhanced by joining to these platforms another excellent drug delivery vehicle, liposomes (Lips) [ 134 , 135 , 136 ], which can be triggered by various chemical/physical stimuli [ 137 , 138 ]. The resulting hybrid systems are multifunctional, as both AuNPs and Lips can be widely decorated on their surface to achieve active/passive targeting delivery systems and/or stimuli-responsive systems.…”
Section: Gold-based Hybrid Nanosystemsmentioning
confidence: 99%